0001415889-17-001664.txt : 20171016
0001415889-17-001664.hdr.sgml : 20171016
20171016160433
ACCESSION NUMBER: 0001415889-17-001664
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20171016
DATE AS OF CHANGE: 20171016
EFFECTIVENESS DATE: 20171016
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Medite Cancer Diagnostics, Inc.
CENTRAL INDEX KEY: 0000075439
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 364296006
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-296791
FILM NUMBER: 171138767
BUSINESS ADDRESS:
STREET 1: 414 NORTH ORLEANS STREET
STREET 2: SUITE 502
CITY: CHICAGO
STATE: IL
ZIP: 60610
BUSINESS PHONE: 4078490290
MAIL ADDRESS:
STREET 1: 414 NORTH ORLEANS STREET
STREET 2: SUITE 502
CITY: CHICAGO
STATE: IL
ZIP: 60610
FORMER COMPANY:
FORMER CONFORMED NAME: CytoCore Inc
DATE OF NAME CHANGE: 20060815
FORMER COMPANY:
FORMER CONFORMED NAME: MOLECULAR DIAGNOSTICS INC
DATE OF NAME CHANGE: 20011009
FORMER COMPANY:
FORMER CONFORMED NAME: AMPERSAND MEDICAL CORP
DATE OF NAME CHANGE: 19990527
D
1
primary_doc.xml
X0708
D
LIVE
0000075439
Medite Cancer Diagnostics, Inc.
4203 SW 34th St
Orlando
FL
FLORIDA
32811
407-996-9630
DELAWARE
None
CytoCore Inc
MOLECULAR DIAGNOSTICS INC
AMPERSAND MEDICAL CORP
Corporation
true
David
Eugene
Patterson
4203 SW 34th St
Orlando
FL
FLORIDA
32811
Executive Officer
Director
Promoter
Michaela
Eugene
Ott
4203 SW 34th St
Orlando
FL
FLORIDA
32811
Director
Michael
Eugene
Ott
4203 SW 34th St
Orlando
FL
FLORIDA
32811
Director
John
Eugene
Abeles, MD
4203 SW 34th St
Orlando
FL
FLORIDA
32811
Director
William
Austin
Lewis IV
4203 SW 34th St
Orlando
FL
FLORIDA
32811
Director
Augusto
Eugene
Ocana
4203 SW 34th St
Orlando
FL
FLORIDA
32811
Director
Eric
Eugene
Goehausen
4203 SW 34th St
Orlando
FL
FLORIDA
32811
Director
Other Health Care
$5,000,001 - $25,000,000
- 06b
false
2017-09-26
false
true
true
true
true
false
25000
Tripoint Global Equities, LLC
143174
None
None
1450 Broadway
26th Floor
New York
NY
NEW YORK
10018
MO
MISSOURI
NY
NEW YORK
VA
VIRGINIA
6856400
5929050
927350
4,560,808 warrants issued exercisable at $0.60 per share.
false
0
6
281875
0
Warrants issued equal to 7.5% of the cash proceeds raised by broker exercisable at $0.60 per share
0
MEDITE CANCER DIAGNOSTICS, INC.
/s/ David E. Patterson
David E. Patterson
Chief Executive Officer
2017-10-16